Text

Universal DX: Microbiome Signatures in Plasma Can Help Detect Early-Stage Colorectal Cancer

Company Presents Data at ESMO Congress Showing Link Between Gut Bacteria and Early Colorectal Cancer Detection

Babies acquire multi-drug-resistant bacteria within hours of birth

Antimicrobial resistant bacteria are present in newborns after just a few hours of life and they help to understand the routes of transmission of antibiotic-resistance genes.

Microbial signature may predict a person’s response to statins

The findings of a new research suggest that different responses to statins can be explained by the variation in the human microbiota.

Lesaffre Acquires Recombia Biosciences and Entry into the World of Synthetic Biology

The acquisition is the culmination of a strategic partnership initiated in 2020 to accelerate the development of yeasts for sustainable production of fermented ingredients.

Digbi Health and Novo Nordisk pilot testing Genetic and Gut Microbiome-based Digital Solutions for Prevention of Obesity

Digbi Health is enrolled in Novo Nordisk's Global Prevention Accelerator Program for the prevention of obesity and related cardiometabolic conditions.

How some gut microbes worsen chronic pain

The findings of a new research illuminate the link between IBS and gut bacteria, and suggest that histamine is a good target for therapies against the condition.

Older siblings may influence a child’s microbiota

The findings of a new research suggest that during the early maturation, the microbiota would be more likely to be influenced by other microbiotas on a not-too-distant level of maturity.

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding Company as AcuraBio

AcuraBio is a globally focussed organization bringing innovative therapeutics to market for customers in the biotech, pharmaceutical, and animal health industries.

Metabolon and University of Oxford Enter Partnership to Identify Biomarkers related to Parkinson’s disease

Metabolon and the Oxford Parkinson's Disease Centre will identify new metabolomic biomarkers to advance Parkinson's research and detect new therapeutic targets

Gut microbes may regulate host physiology by metabolizing vitamin A

The results of a new research done in mice suggest that gut bacteria can regulate host physiology by metabolizing vitamin A.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top